STAT5A and neoplasm: As expected, the result found that STAT5A expression was remarkably downregulated in BRCA compared with healthy control in subgroup analyses based on race, age, gender, race, subclasses, tumor histology, menopause status, nodal metastasis status, and TP53 mutation (Fig. 3).